“DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA” (2019) Mediterranean Journal of Hematology and Infectious Diseases, 11(1), p. e2019016. doi:10.4084/mjhid.2019.016.